UK

VPAS 2024: What should industry consider next time?

https://pharmaphorum.com/views-analysis-market-access/vpas-2024-what-should-industry-consider-next-time/

Market access round-up: the UK opens up to innovation

https://pharmaphorum.com/views-and-analysis/market-access-roundup-the-uk-opens-up-to-innovation/

R&D Roundup: Pharma gets in on the biotech boom

https://pharmaphorum.com/r-d/views-analysis-r-d/rd-roundup-pharma-gets-in-on-the-biotech-boom/

UK pharma patents up 20%, new report finds

https://pharmaphorum.com/news/uk-pharma-patents-up-20-new-report-finds/

Pharma’s apprentice army is sculpting the future

https://pharmaphorum.com/r-d/views-analysis-r-d/pharmas-apprentice-army-is-sculpting-the-future/

Digital health market to top $379bn by 2024

https://pharmaphorum.com/news/digital-health-market-to-top-379bn-by-2024/

Makara Health bolsters team with new hires

https://pharmaphorum.com/partner-content/makara-health-bolsters-team-with-new-hires/

Orphan medicines, advances, access and affordability

https://pharmaphorum.com/partner-content-market-access/orphan-medicines-advances-access-affordability/

Getting it right: the UK’s pathway for 2017

https://pharmaphorum.com/views-and-analysis/getting-right-uks-pathway-2017/

1 2 3

Close in 10 seconds

Pharmaphorum.com

Search